Plasminogen deficiency: type I (hypoplasminogenaemia) vs type II (dysplasminogenaemia)
- Look-alikes compared
Plasmin is the clean-up crew for fibrin. Without it, small wounds on the eye, gums or airway heal under thick woody membranes that keep coming back.
What it is
Plasminogen is the inactive precursor of plasmin, the enzyme that dissolves fibrin. Congenital plasminogen deficiency is autosomal recessive (PLG gene) and very rare, estimated at 1.6 per million. In type I (hypoplasminogenaemia) both activity and antigen are low, and fibrin-rich, firm (ligneous) pseudomembranes grow on mucous membranes after minor injury or infection: the conjunctiva most of all, but also gums, airway, ears, female genital tract, kidneys and, in severe cases, the brain's fluid pathways (congenital occlusive hydrocephalus). In type II (dysplasminogenaemia) the antigen is normal but activity is low, and most people have no symptoms. Despite being a fibrinolysis defect, plasminogen deficiency has not been shown to cause thrombosis.
The difference in one line
- Type I: low plasminogen activity and antigen; most patients have activity below 50% (normal about 70% to 130%, assay dependent).
- Type II: normal antigen, low activity; usually no symptoms. Heterozygous carriers of either type are asymptomatic.
- Ligneous conjunctivitis is the commonest lesion (about 81%); about a third have corneal involvement that can threaten sight.
- Other sites: gums (about 30%, with periodontal destruction and tooth loss), airway (about 20%), ears (about 14%), female genital tract (about 9%), kidneys (about 4%).
- Congenital occlusive hydrocephalus occurs in the most severe type I cases, thought to be from fibrin blocking fluid drainage; shunts into the peritoneum often fail.
- No proven link with venous or arterial thrombosis, even though the first case described had recurrent clots.
Too few crew or blunt tools
| Feature | Type I: hypoplasminogenaemia | Type II: dysplasminogenaemia | Heterozygous carrier |
|---|---|---|---|
| What is wrong | Too little plasminogen, and what there is may work poorly | Normal amount, poor function | One faulty PLG copy |
| Plasminogen activity | Low (usually below 50%) | Low | Mildly low |
| Plasminogen antigen | Low | Normal | Mildly low or normal |
| Symptoms | Ligneous pseudomembranes, often starting in infancy | Usually none | None |
| Typical sites | Conjunctiva, cornea, gums, airway, ears, genital tract, kidneys; occlusive hydrocephalus in severe cases | Rarely any | None |
| Thrombosis | Not shown to be increased | Not shown to be increased | Not shown to be increased |
| Treatment in principle | Plasminogen replacement (intravenous where approved; eye drops on compassionate use); plasma as a stopgap; surgery only with plasminogen cover | Usually none | None; genetic counselling for the family |
In clinical practice
- A baby or child with thick, yellow-white, woody membranes on the inside of the eyelids that recur after every cold should have plasminogen activity and antigen measured.
- Gum swelling with early tooth loss, hoarseness or noisy breathing, recurrent ear discharge or a vaginal membrane in the same child points to the same systemic disease.
- A newborn with macrocephaly and ventricular enlargement plus ligneous conjunctivitis suggests severe type I disease; peritoneal shunts block often, and other drainage routes have been used.
- Peeling or excising the membranes alone triggers fresh ones, because the operation is a new injury; it is planned with plasminogen cover.
- Before replacement became available, treatment relied on topical heparin, steroids, ciclosporin and plasma, with limited and inconsistent success.
How it is confirmed
- Measure plasminogen activity (functional assay) and plasminogen antigen; both low means type I, normal antigen with low activity means type II.
- There is no screening clotting test: PT, aPTT and fibrinogen are normal, so the diagnosis is missed unless plasminogen is asked for specifically.
- Confirm with PLG genetic testing and, when a membrane is removed, histology showing fibrin-rich material.
- Interpret levels with the laboratory's own reference range and the patient's age; test parents and siblings to find carriers.
- Treatment in principle: plasminogen replacement where available, with activity monitored to keep lesions controlled; no thrombophilia work-up is needed because of the deficiency alone.
Common traps
- Expecting a fibrinolysis defect to cause thrombosis: plasminogen deficiency causes fibrin membranes on mucous surfaces, not clots in vessels; other enzymes still clear fibrin in blood.
- Treating ligneous conjunctivitis as an infection: antibiotics do not help; the membrane is fibrin that plasmin cannot clear.
- Simply peeling the membranes off: surgery is a new wound that lays down fresh fibrin, so membranes return unless plasminogen is replaced.
- Thinking ligneous conjunctivitis is an eye-only disease: the deficiency is systemic, and the gums, airway, ears, kidneys and genital tract can be involved.
- Labelling a normal-antigen, low-activity result as harmless type I: that pattern is type II, which is usually asymptomatic, while type I has low antigen.
Test yourself
Think of the answer, then tap the question to see it.
Why does a defect in clot breakdown give membranes on the conjunctiva rather than deep vein thrombosis?
Every small mucosal injury lays down fibrin that plasmin would normally clear; without it the fibrin builds up and hardens, while in flowing blood other enzymes can still dissolve fibrin.
Plasminogen activity is low and antigen is normal in an adult with no symptoms. Which type is this?
Type II plasminogen deficiency (dysplasminogenaemia), which is usually asymptomatic.
A child's ligneous membranes come back weeks after each surgical removal. Why, and what changes the outcome?
The surgical wound lays down new fibrin that cannot be cleared; plasminogen replacement before and after surgery prevents recurrence.
Why are routine coagulation screens unhelpful in suspected plasminogen deficiency?
PT and aPTT measure clot formation, not clot breakdown, so they are normal; plasminogen activity and antigen must be requested specifically.
Elsewhere in DurgiPedia
- Fibrinolysis and natural anticoagulants
- Conjunctiva: conjunctivitis, trachoma and pterygium
- Hypercoagulable states: inherited and acquired
Connections
Educational content; it does not replace assessment by a doctor or your institution's protocols. It contains no doses.
Sources: Congenital plasminogen deficiency: MedlinePlus Genetics (MedlinePlus Genetics, US National Library of Medicine, 2026); PLG gene: MedlinePlus Genetics (MedlinePlus Genetics, US National Library of Medicine, 2012); An international registry of patients with plasminogen deficiency (HISTORY) (Haematologica, PMC open access, 2020); The unravelling of the genetic architecture of plasminogen deficiency and its relation to thrombotic disease (Scientific Reports, PMC open access, 2016); Congenital hydrocephalus and ligneous conjunctivitis in two children with severe type I plasminogen deficiency: a case report and literature review (SAGE Open Medical Case Reports, PMC open access, 2024); Case report: respiratory lesions successfully treated with intravenous plasminogen replacement therapy in four patients with plasminogen deficiency type 1 (Frontiers in Pediatrics, PMC open access, 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
